Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses

Por Warren, Richard B., See, Kyoungah, Burge, Russel, Zhang, Ying, Brnabic, Alan, Gallo, Gaia, Garrelts, Alyssa, Egeberg, Alexander
Publicado no Dermatol Ther (Heidelb) (2019)

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

Por Combe, Bernard, Rahman, Proton, Kameda, Hideto, Cañete, Juan D., Gallo, Gaia, Agada, Noah, Xu, Wen, Genovese, Mark C.
Publicado no Arthritis Res Ther (2020)

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

Por Gladman, Dafna D., Orbai, Ana-Maria, Klitz, Uta, Wei, James Cheng-Chung, Gallo, Gaia, Birt, Julie, Rathmann, Suchitrita, Shrom, David, Marzo-Ortega, Helena
Publicado no Arthritis Res Ther (2019)

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis

Por Mease, Philip, Walsh, Jessica A., Baraliakos, Xenofon, Inman, Robert, de Vlam, Kurt, Wei, James Cheng-Chung, Hunter, Theresa, Gallo, Gaia, Sandoval, David, Zhao, Fangyi, Dong, Yan, Bolce, Rebecca, Marzo-Ortega, Helena
Publicado no Rheumatol Ther (2019)

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

Por Armstrong, April, Paul, Carle, Puig, Luis, Boehncke, Wolf Henning, Freeman, Michael, Torii, Hideshi, Papp, Kim, Griffiths, Christopher E. M., Blauvelt, Andrew, Reich, Kristian, Gooderham, Melinda, Terui, Tadashi, Renda, Lisa, Agada, Noah, Xu, Wen, Gallo, Gaia, Lebwohl, Mark G.
Publicado no Dermatol Ther (Heidelb) (2019)

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Por Leonardi, Craig, Reich, Kristian, Foley, Peter, Torii, Hideshi, Gerdes, Sascha, Guenther, Lyn, Gooderham, Melinda, Ferris, Laura K., Griffiths, Christopher E. M., ElMaraghy, Hany, Crane, Heidi, Patel, Himanshu, Burge, Russel, Gallo, Gaia, Shrom, David, Leung, Ann, Lin, Chen-Yen, Papp, Kim
Publicado no Dermatol Ther (Heidelb) (2020)

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and...

Por Dougados, Maxime, Wei, James Cheng-Chung, Landewé, Robert, Sieper, Joachim, Baraliakos, Xenofon, Van den Bosch, Filip, Maksymowych, Walter P, Ermann, Joerg, Walsh, Jessica A, Tomita, Tetsuya, Deodhar, Atul, van der Heijde, Désirée, Li, Xiaoqi, Zhao, Fangyi, Bertram, Clinton C, Gallo, Gaia, Carlier, Hilde, Gensler, Lianne S
Publicado no Ann Rheum Dis (2020)